Glucose
While it was previously believed that tight glycaemic control (blood glucose 80–110 mg/dL) was beneficial, data from the NICE-SUGAR trial have demonstrated increased mortality with this approach compared to conventional glucose control (blood glucose 180 mg/dL).60 It is now recommended thata protocoled approach to insulin dosing begins only after two blood glucose measurements > 180 mg/dL.